Literature DB >> 17018696

Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study.

Iñigo Rojas-Marcos1, Francesc Graus, Gema Sanz, Arturo Robledo, Carlos Diaz-Espejo.   

Abstract

We describe a patient who presented with excessive daytime sleepiness (EDS) and was eventually diagnosed with anti-Ma2 encephalitis. Neurological examination disclosed somnolence, left palpebral ptosis, and vertical gaze paresis. A brain MRI showed high signal intensity in the hypothalamus and each hippocampus. Ma2 antibodies were found in the patient's serum, and fiberbronchoscopy disclosed a lung carcinoma. After three months of steroid treatment, the results of the patient's neurological exam became normal. We conclude that anti-Ma2 encephalitis may present with mostly isolated EDS and that it may respond to steroids despite old age and the presence of an untreated lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018696      PMCID: PMC1828100          DOI: 10.1215/15228517-2006-013

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  10 in total

1.  Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis.

Authors:  R Scheid; R Voltz; T Guthke; J Bauer; D Sammler; D Y von Cramon
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

Review 2.  CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.

Authors:  J Arii; T Kanbayashi; Y Tanabe; Y Sawaishi; S Kimura; A Watanabe; K Mishima; Y Hishikawa; T Shimizu; S Nishino
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

3.  CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

Authors:  B Ripley; S Overeem; N Fujiki; S Nevsimalova; M Uchino; J Yesavage; D Di Monte; K Dohi; A Melberg; G J Lammers; Y Nishida; F W Roelandse; M Hungs; E Mignot; S Nishino
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

4.  Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.

Authors:  M R Rosenfeld; J G Eichen; D F Wade; J B Posner; J Dalmau
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

5.  A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Authors:  R Voltz; S H Gultekin; M R Rosenfeld; E Gerstner; J Eichen; J B Posner; J Dalmau
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

6.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Authors:  Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Journal:  Arch Neurol       Date:  2002-10

7.  Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.

Authors:  S Overeem; J Dalmau; L Bataller; S Nishino; E Mignot; J Verschuuren; G J Lammers
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

8.  Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study.

Authors:  Joseph C Landolfi; Mangala Nadkarni
Journal:  Neuro Oncol       Date:  2003-07       Impact factor: 12.300

Review 9.  Sleep, sleep disorders and hypocretin (orexin).

Authors:  Emmanuel Mignot
Journal:  Sleep Med       Date:  2004-06       Impact factor: 3.492

10.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

  10 in total
  7 in total

Review 1.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

Review 2.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

3.  REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis.

Authors:  Yaroslau Compta; Alex Iranzo; Joan Santamaría; Roser Casamitjana; Francesc Graus
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

4.  Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing.

Authors:  Eleonora Rigoni; Lisa Farina; Paola Bini; Patrizia Morbini; Diego Franciotta; Matteo Gastaldi
Journal:  Neurol Sci       Date:  2020-09-29       Impact factor: 3.307

Review 5.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

6.  Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients.

Authors:  Stefan Macher; Friedrich Zimprich; Desiree De Simoni; Romana Höftberger; Paulus S Rommer
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

7.  Anti-Ma2-associated limbic encephalitis with coexisting chronic inflammatory demyelinating polyneuropathy in a patient with non-Hodgkin lymphoma: A case report.

Authors:  Weina Ju; Baochang Qi; Xu Wang; Yu Yang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.